Small Molecule Inhibitors - Catalysis

Relevant Publications

Small molecule NMD and MDM2 inhibitors synergistically trigger apoptosis in HeLa cells.

Issue Release: 2024

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.

Issue Release: 2024

Selective inhibition of c-Met signaling pathways with a bispecific DNA nanoconnector for the targeted therapy of cancer.

Issue Release: 2024

A designed ankyrin-repeat protein that targets Parkinson\'s disease-associated LRRK2.

Issue Release: 2024

The Notch inhibitor, FLI-06, increases the chemosensitivity of head and neck Squamous cell carcinoma cells to taxanes-based treatment.

Issue Release: 2024

N-phenyl pyrazoline derivative inhibits cell aggressiveness and enhances paclitaxel sensitivity of triple negative breast cancer cells.

Issue Release: 2024

Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance.

Issue Release: 2024

Targeting the RAS upstream and downstream signaling pathway for Cancer treatment.

Issue Release: 2024

The small GTPase Cdc42 regulates shell field morphogenesis in a gastropod mollusk.

Issue Release: 2024

A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors.

Issue Release: 2024

Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cells.

Issue Release: 2024

Druggability Analysis of Protein Targets for Drug Discovery to Combat .

Issue Release: 2024

Early Effects of Modern Radiotherapy for Lung Cancer on Endothelial Damage and Myocardial Fibrosis: A Prospective Single-Center Study.

Issue Release: 2024

Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. 2022, , 8282.

Issue Release: 2024

Targeting the STAT3 pathway with STAT3 degraders.

Issue Release: 2024

An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR-ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia.

Issue Release: 2024

Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging.

Issue Release: 2024

Pulsatillic acid as a potential inhibitor of protein kinase C-alpha in non-small cell lung cancer.

Issue Release: 2024

Discovery Small-Molecule p300 Inhibitors Derived from a Newly Developed Indazolone-Focused DNA-Encoded Library.

Issue Release: 2024

Baicalin induces cell death of non-small cell lung cancer cells via MCOLN3-mediated lysosomal dysfunction and autophagy blockage.

Issue Release: 2024

How Does Catalyst B Work?

What Challenges Does Heterogeneous Catalysis Face?

What are Poison Resistant Catalysts?

What is Batch Testing in Catalysis?

What role do environmental regulations play in shaping regional catalysis practices?

What are the Future Directions of Lehn's Research in Catalysis?

What Tools are Commonly Used for Text Mining in Catalysis?

How is Inert Gas Drying Performed?

How to Prevent Mechanical Failure?

What are Additives and Promoters?

Partnered Content Networks

Relevant Topics